CAREERS AT BIOMARIN
Our focus on rare disease gives us the rare opportunity to truly impact lives.
Learn More about careers with BioMarin ⌃
OUR MOTIVATION
We are inspired and driven everyday by stories like Sheri’s.
Learn More about Sheri ⌃
Patient & Community Support
Treatment is only the beginning.
We are committed to the communities we treat beyond the therapies
OUR PIPELINE
We take on the biggest challenges in rare disease.
Each drug candidate we pursue is guided by a fundamental understanding of the genetics and underlying biology of the condition it
-
November 30, 2021BioMarin to Hold Virtual R&D Day at 11:00am ET Today
-
November 29, 2021BioMarin to Participate in Two Upcoming Virtual Investor Conferences
-
November 19, 2021BioMarin Receives FDA Approval for VOXZOGO™ (vosoritide) for Injection, Indicated to Increase Linear Growth in Children with Achondroplasia Aged 5 and Up with Open Growth Plates
-
October 27, 2021BioMarin Announces Third Quarter 2021 Financial Results and Corporate Updates
-
October 25, 2021BioMarin to Participate in Four Upcoming Virtual Investor Conferences
-
October 12, 2021BioMarin to Host Third Quarter 2021 Financial Results Conference Call and Webcast on Wednesday, October 27 at 4:30pm ET
-
October 4, 2021BioMarin Hires Industry Veterans to Fill Key Roles in R&D and Technical Operations
-
November 17, 2020BioMarin and Deep Genomics to Collaborate on Advancing Programs Identified Using Artificial Intelligence